Inspire, Nourish, Thrive Every Day.
|
|
Type
|
Public (60% privately owned) |
---|---|
Traded as | NYSE: VSI S&P 600 Component |
Industry | Retail |
Founded | 1977 |
Headquarters | North Bergen, New Jersey, United States |
Number of locations
|
775 (December 2016) |
Key people
|
Colin Watts, CEO; Brenda M. Galgano, Executive VP and CFO |
Products | Nutritional supplements |
Website | www.vitaminshoppe.com |
Colin Watts, CEO;
The Vitamin Shoppe (formerly Vitamin Shoppe Industries, Inc., stylized as theVitaminShoppe) is an American, New Jersey-based retailer of nutritional supplements. It also operated 3 stores in Canada under the name VitaPath from January 2013 until March 2016. The company provides approximately 8,000 different SKUs of supplements through its retail stores and over 20,000 different SKUs of supplements through its retail websites.
In 2002, Vitamin Shoppe Industries was sold to an affiliate of Bear Stearns Merchant Banking, a private equity unit of Bear Stearns, for approximately $310 million.
The Vitamin Shoppe held an initial public offering on October 26, 2009. The company made $751.5 million in net sales in fiscal 2010 and had a market capitalization of over $1 billion.. Since attaining it's peak in February 2013 the stock has lost more than 90% of it's value as of August 2017.
Jeffrey Horowitz founded The Vitamin Shoppe in 1977.
The Vitamin Shoppe's retail stores and online sites carry a line of nutritional supplements with supplementary lines, such as Mytrition, Next Step, ProBio Care, plnt and the Bodytech brand of sports supplements. In addition to their own brands, the company carries third-party lines, including professional and specialized lines.
A 2015 study, led by Dr. Pieter A. Cohen of Harvard, found that three supplements — JetFuel Superburn, JetFuel T-300 and MX-LS7 — sold at Vitamin Shoppe contained BMPEA. In response, Vitamin Shoppe removed these products from shelves because the safety of these supplements were in question and may not comply with F.D.A. regulations.
On January 19, 2007, independent laboratory ConsumerLab.com found 32.8 micrograms of lead per daily serving in Vitamin Shoppe's "Especially for Women" multivitamin. 15.3 micrograms is more than ten times the amount of lead permitted without a warning label in California, the only state to regulate lead in supplements. The amount of lead found was found to cause cancer and death to 29 people nationwide. In the wake of extensive adverse media coverage, Vitamin Shoppe withdrew the product, but in a statement made by CEO Tom Tolworthy denied it had any proof the vitamins were contaminated and asserted that, despite the high lead levels found in the Consumer Labs tests, its vitamins were manufactured in accordance with "good manufacturing practices."
On June 15, 2011, Vitamin Shoppe's Ultimate Woman Gold multivitamin was tested by ConsumerLab.com in their Multivitamin and Multimineral Supplements Review of 38 of the leading multivitamin/multimineral products sold in the U.S. and Canada. This multivitamin passed ConsumerLab's test, which included testing of selected index elements, their ability to disintegrate in solution per United States Pharmacopeia guidelines, lead contamination threshold set in California Proposition 65, and meeting U.S. Food and Drug Administration (FDA) labeling requirements.
2016-05-16 | Reiterated Rating | Robert W. Baird | Hold | |
2016-05-16 | Reiterated Rating | Sterne Agee CRT | Neutral | |
2016-05-06 | Reiterated Rating | Jefferies Group | Hold | $30.00 to $32.00 |
2016-05-05 | Reiterated Rating | Macquarie | Neutral | $40.00 |
2016-04-30 | Downgrade | Goldman Sachs | Hold | |
2016-04-30 | Downgrade | Goldman Sachs Group Inc. | Hold | |
2016-04-26 | Reiterated Rating | Robert W. Baird | Hold | |
2016-04-20 | Initiated Coverage | Wedbush | Outperform | $39.00 |
2016-04-15 | Reiterated Rating | Piper Jaffray | Neutral | $30.00 |
2016-04-15 | Reiterated Rating | Piper Jaffray Cos. | Neutral | $30.00 |
2016-03-28 | Downgrade | William Blair | Market Perform | |
2016-02-26 | Lower Price Target | Goldman Sachs | $39.00 to $34.00 | |
2016-02-24 | Reiterated Rating | Piper Jaffray | Neutral | $34.00 to $30.00 |
2016-02-24 | Lower Price Target | Jefferies Group | Hold | $36.00 to $30.00 |
2016-02-24 | Reiterated Rating | Deutsche Bank | Hold | $37.00 to $30.00 |
2016-02-24 | Lower Price Target | Barclays | Equal Weight | $35.00 to $31.00 |
2016-02-24 | Reiterated Rating | Deutsche Bank AG | Hold | $37.00 to $30.00 |
2016-02-24 | Lower Price Target | Barclays PLC | Equal Weight | $35.00 to $31.00 |
2016-02-22 | Lower Price Target | Sterne Agee CRT | Neutral | $35.00 to $34.00 |
2016-01-27 | Reiterated Rating | Piper Jaffray | Neutral | $35.00 to $34.00 |
2016-01-12 | Lower Price Target | Goldman Sachs | $42.00 to $39.00 | |
2016-01-07 | Lower Price Target | Jefferies Group | Hold | $36.00 |
2015-12-13 | Reiterated Rating | Bank of America | Underperform | $26.00 to $28.00 |
2015-12-13 | Reiterated Rating | Bank of America Corp. | Underperform | $26.00 to $28.00 |
2015-11-17 | Downgrade | Robert W. Baird | Outperform to Neutral | $38.00 to $31.00 |
2015-11-05 | Lower Price Target | Deutsche Bank | Hold | $41.00 to $37.00 |
2015-11-04 | Reiterated Rating | Bank of America | Sell | |
2015-11-04 | Reiterated Rating | Robert W. Baird | Buy | |
2015-08-07 | Downgrade | Tigress Financial | Buy to Neutral | |
2015-08-06 | Lower Price Target | Barclays | Equal Weight | $40.00 to $38.00 |
2015-08-06 | Reiterated Rating | Deutsche Bank | Hold | $43.00 to $41.00 |
2015-07-28 | Reiterated Rating | Robert W. Baird | Buy | |
2015-06-09 | Reiterated Rating | Guggenheim | Neutral | $40.00 |
2015-06-09 | Initiated Coverage | Macquarie | Neutral | $40.00 |
2015-05-07 | Set Price Target | Barclays | Equal Weight | $45.00 to $40.00 |
2015-02-25 | Reiterated Rating | Jefferies Group | Hold | $44.00 to $43.00 |
2015-02-25 | Reiterated Rating | Piper Jaffray | In-Line | $42.00 |
2015-02-25 | Downgrade | Barclays | Overweight to Equal Weight | $51.00 to $45.00 |
2015-02-19 | Reiterated Rating | Deutsche Bank | Hold | $43.00 |
2015-01-08 | Downgrade | Bank of America | Neutral to Underperform | $40.00 |
2014-12-04 | Initiated Coverage | Stephens | Overweight | |
2014-11-07 | Downgrade | Goldman Sachs | Buy to Neutral | $49.00 to $48.00 |
2014-11-04 | Downgrade | Wedbush | Outperform to Neutral | $50.00 to $45.00 |
2014-11-04 | Downgrade | Sterne Agee CRT | Buy to Neutral | $53.00 to $42.00 |
2014-11-04 | Downgrade | Deutsche Bank | Buy to Hold | $50.00 to $43.00 |
2014-10-01 | Reiterated Rating | Bank of America | Buy | $45.00 to $49.00 |
2014-09-30 | Downgrade | Piper Jaffray | Overweight to Neutral | $45.00 to $44.00 |
2014-09-19 | Reiterated Rating | Morgan Stanley | Overweight | $49.00 |
2014-09-11 | Upgrade | Morgan Stanley | Overweight | $49.00 |
2014-08-06 | Reiterated Rating | Deutsche Bank | Buy | $55.00 to $50.00 |
2014-08-06 | Reiterated Rating | JPMorgan Chase & Co. | Overweight | $54.00 to $49.00 |
2014-08-06 | Reiterated Rating | Longbow Research | Buy | $59.00 to $55.00 |
2014-08-06 | Lower Price Target | Morgan Stanley | $49.00 | |
2014-08-06 | Downgrade | Goldman Sachs | Conviction-Buy to Buy | |
2014-06-24 | Initiated Coverage | Morgan Stanley | Overweight | $54.00 |
2014-06-04 | Upgrade | Bank of America | Underperform to Neutral | $47.00 |
2014-05-09 | Upgrade | Barclays | Equal Weight to Overweight | $49.00 to $51.00 |
2014-05-09 | Boost Price Target | Jefferies Group | $45.00 to $48.00 | |
2014-04-23 | Upgrade | Sterne Agee CRT | Neutral to Buy | $49.00 to $57.00 |
2014-01-23 | Downgrade | William Blair | Outperform to Market Perform | |
2013-11-18 | Upgrade | Goldman Sachs | Buy to Conviction-Buy | $59.00 to $65.00 |
2013-11-06 | Reiterated Rating | Jefferies Group | Hold | $42.00 |
2013-11-06 | Boost Price Target | Deutsche Bank | Buy | $52.00 to $55.00 |
2013-11-01 | Initiated Coverage | Buckingham Research | Neutral | |
2013-10-07 | Initiated Coverage | Jefferies Group | Hold | $42.00 |
2013-09-25 | Initiated Coverage | Deutsche Bank | Buy | $52.00 |
2013-09-24 | Initiated Coverage | Barclays | Equal Weight | |
2009-12-07 | Initiated | Stifel Nicolaus | Buy | $24 |
2009-11-23 | Initiated | Pali Research | Buy |
2016-05-16 | Reiterated Rating | Robert W. Baird | Hold | |
2016-05-16 | Reiterated Rating | Sterne Agee CRT | Neutral | |
2016-05-06 | Reiterated Rating | Jefferies Group | Hold | $30.00 to $32.00 |
2016-05-05 | Reiterated Rating | Macquarie | Neutral | $40.00 |
2016-04-30 | Downgrade | Goldman Sachs | Hold |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In VSI 18 funds of 2213 total. Show all
Fund name | Ticker shares |
---|---|
BlackRock Fund Advisors | 1.95M |
BlackRock Institutional Trust Company, N.A. | 0.68M |
MANAGED ACCOUNT ADVISORS LLC | 0.23M |
BlackRock Investment Management, LLC | 0.13M |
MENTA CAPITAL LLC | 0.12M |
PEAK6 Investments, L.P. | 0.11M |
OPPENHEIMER FUNDS INC | 86717 |
BlackRock Group LTD | 53430 |
CATAPULT CAPITAL MANAGEMENT LLC | 48964 |
Loeb Offshore Management LP | 47383 |
DECADE CAPITAL MANAGEMENT LLC | 33000 |
Jump Trading, LLC | 26785 |
Airain ltd | 22262 |
VTL Associates, LLC | 19758 |
CAPSTONE ASSET MANAGEMENT CO | 14040 |
Name Relationship | Total Shares | Holding stocks |
---|---|---|
SHAH CAPITAL MANAGEMENT | 13.84% (4276142) | VSI / XNY / |
Vintage Capital Management LLC | 11.61% (3587255) | ANEN / VSI / |
Watts Colin Frederick Chief Executive Officer | 0.42% (129102) | VSI / |
TRUESDALE ANTHONY N Chief Executive Officer | 0.33% (102732) | VSI / |
MARKEE RICHARD L ExecutiveChairman of the Board | 0.19% (60185) | FIVE / VSI / |
GALGANO BRENDA Chief Financial Officer | 0.19% (60073) | VSI / |
BOWLIN JOHN D | 0.18% (56028) | GNRC / VSI / |
Reiser Jason S COO | 0.11% (35405) | DG / DLTR / FDO / VSI / |
Kastin David See Remarks | 0.09% (29127) | CLUB / VSI / |
LAMADRID DAN VP, Controller & CAO | 0.07% (22755) | ASNA / VSI / |
Beardall Michael James See Remarks | 0.06% (18468) | VSI / |
Weiss Louis VP and Chief Marketing Officer | 0.05% (16923) | SSTK / VSI / |
ARCHBOLD MICHAEL G President & COO | 0.05% (16476) | EXPR / GNC / VSI / |
EDWAB DAVID H | 0.05% (16128) | MW / NWY / VSI / |
ALFONSO ANTHONY President, Nutri-Force | 0.05% (15424) | VSI / |
FRYDMAN JEAN W See Remarks | 0.05% (15202) | VSI / |
PRITCHARD BETH M | 0.05% (14268) | BRDR / CAB / VSI / ZLC / |
DERBY DEBORAH | 0.04% (12904) | VSI / |
Becker B. Michael | 0.04% (10881) | MW / VSI / |
Marmol Guillermo | 0.03% (9631) | FL / III / VSI / |
THERIAULT TIMOTHY J | 0.03% (8631) | ADS / VSI / WAG / |
Sander James M VP, Gen Counsel & Corp Sec\'y | 0.03% (8081) | GNC / VSI / |
EDMONDSON JOHN | 0.02% (7206) | CAB / VSI / |
PERKAL RICHARD | 0.02% (6534) | VSI / |
Dolgin Tracy Scott | 0.02% (6452) | VSI / |
SMITH ALEX | 0.02% (6452) | PIR / TUMI / VSI / |
Buggeln Catherine Elizabeth | 0.02% (5953) | ASNA / FIVE / VSI / |